19.09
Schlusskurs vom Vortag:
$19.12
Offen:
$19.05
24-Stunden-Volumen:
345.08K
Relative Volume:
0.55
Marktkapitalisierung:
$1.43B
Einnahmen:
$122.87M
Nettoeinkommen (Verlust:
$-73.68M
KGV:
-19.47
EPS:
-0.9803
Netto-Cashflow:
$-39.27M
1W Leistung:
+7.58%
1M Leistung:
+11.74%
6M Leistung:
+46.69%
1J Leistung:
+39.31%
Zymeworks Inc. Stock (ZYME) Company Profile
Firmenname
Zymeworks Inc.
Sektor
Branche
Telefon
604-678-1388
Adresse
1385 West 8th Avenue, Suite 540, Vancouver, BC
Vergleichen Sie ZYME mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ZYME
Zymeworks Inc.
|
19.09 | 1.45B | 122.87M | -73.68M | -39.27M | -0.9803 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-24 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-10-14 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-10-10 | Eingeleitet | B. Riley Securities | Buy |
| 2025-05-20 | Eingeleitet | TD Cowen | Buy |
| 2024-12-16 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-11-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-11-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-21 | Fortgesetzt | Wells Fargo | Overweight |
| 2023-01-04 | Bestätigt | H.C. Wainwright | Neutral |
| 2022-12-20 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-10-21 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-10-04 | Fortgesetzt | Wells Fargo | Overweight |
| 2022-05-05 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-03-15 | Eingeleitet | Evercore ISI | Outperform |
| 2021-12-10 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-17 | Fortgesetzt | Guggenheim | Neutral |
| 2021-10-07 | Eingeleitet | Jefferies | Hold |
| 2021-03-31 | Eingeleitet | Credit Suisse | Outperform |
| 2021-02-25 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-02-08 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-01-25 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-09-29 | Fortgesetzt | JP Morgan | Neutral |
| 2020-08-06 | Eingeleitet | SVB Leerink | Outperform |
| 2020-01-10 | Eingeleitet | Wolfe Research | Outperform |
| 2019-12-09 | Eingeleitet | JP Morgan | Neutral |
| 2019-11-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-11-20 | Eingeleitet | Guggenheim | Buy |
| 2019-09-30 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-08-30 | Eingeleitet | Stifel | Buy |
| 2019-07-18 | Eingeleitet | Deutsche Bank | Buy |
| 2018-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2018-03-19 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Zymeworks Inc. Aktie (ZYME) Neueste Nachrichten
How Zymeworks Inc. (ZA8) stock performs in volatility spikesJuly 2025 Volume & Comprehensive Market Scan Reports - newser.com
Will Zymeworks Inc. stock gain from strong economyQuarterly Market Summary & Precise Trade Entry Recommendations - newser.com
How to use Fibonacci retracement on Zymeworks Inc.Quarterly Market Summary & Real-Time Volume Analysis Alerts - newser.com
Custom strategy builders for tracking Zymeworks Inc.Trade Risk Assessment & Verified Swing Trading Watchlists - newser.com
Why Zymeworks Inc. (ZA8) stock could outperform next yearQuarterly Growth Report & Technical Pattern Recognition Alerts - newser.com
How Zymeworks Inc. (ZA8) stock stacks up against competitors2025 Key Highlights & Capital Protection Trading Alerts - newser.com
Why Zymeworks Inc. stock is in analyst buy zoneWatch List & Verified Momentum Stock Alerts - newser.com
Is Zymeworks Inc. (ZA8) stock nearing a technical breakout2025 Price Targets & Smart Allocation Stock Reports - newser.com
Will Zymeworks Inc. stock attract ESG investorsLong Setup & Consistent Growth Stock Picks - newser.com
Is Zymeworks Inc. (ZA8) stock cheap vs fundamentalsJuly 2025 Highlights & Real-Time Buy Signal Notifications - newser.com
Zymeworks, Inc. Hits New 52-Week High at $19.98 - Markets Mojo
Zymeworks Inc. (NASDAQ:ZYME) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Zymeworks (NASDAQ:ZYME) Reaches New 52-Week HighStill a Buy? - MarketBeat
Zymeworks stock hits 52-week high at $19.87 By Investing.com - Investing.com Australia
Applying Elliott Wave Theory to Zymeworks Inc.Market Growth Summary & Free High Accuracy Swing Entry Alerts - newser.com
How Zymeworks Inc. stock compares to market leadersJuly 2025 Fed Impact & Advanced Technical Analysis Signals - newser.com
Is now a turning point for Zymeworks Inc.Index Update & Fast Entry High Yield Stock Tips - newser.com
Will Zymeworks Inc. stock sustain high P E ratiosGap Down & Fast Entry and Exit Trade Plans - newser.com
What sentiment indicators say about Zymeworks Inc. stock2025 Breakouts & Breakdowns & Intraday High Probability Alerts - newser.com
Zymeworks stock hits 52-week high at $19.87 - Investing.com
Zymeworks Inc. (ZYME) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Can Zymeworks Inc. stock resist market sell offsTrend Reversal & Reliable Trade Execution Plans - newser.com
Zymeworks (ZYME) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Zymeworks (ZYME) Upgraded to Strong Buy: Here's What You Should Know - sharewise.com
Zymeworks (ZYME) Price Target Increased by 12.22% to 25.24 - Nasdaq
Is Zymeworks Inc. forming a bottoming baseJuly 2025 Closing Moves & Real-Time Buy Zone Alerts - newser.com
Zymeworks (NYSE:ZYME) Sees Strong Trading VolumeWhat's Next? - MarketBeat
Zymeworks (NASDAQ:ZYME) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Finanzdaten der Zymeworks Inc.-Aktie (ZYME)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):